LouisBNaborsIIIMD

Neurology • Birmingham, AL

Neurooncology

Professor, Neurology, University of Alabama School of Medicine

Join to view full profile

Dr. Nabors is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nabors' full profile

Already have an account?

Office
510 3rd Ave S
Birmingham, AL 35294
Phone+1 205-934-1432

Fax+1 205-975-7546
Is this information wrong?

Summary

Director, Neuro-Oncology

Education & Training

University of Alabama Medical CenterResidency, Neurology, 1995 - 1998
National Capital ConsortiumInternship, Internal Medicine, 1991 - 1992
University of Tennessee Health Science Center College of MedicineClass of 1991

Certifications & Licensure

AL State Medical License 1995 - 2024
FL State Medical License 1994 - 1996
American Board of Psychiatry and Neurology Neurology

Clinical Trials

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma Start of enrollment: 2000 Sep 01
Completed
Phase 1, Phase 2
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2005 Apr 01
Completed
Phase 1, Phase 2
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma Start of enrollment: 2004 Dec 01
Completed
Phase 1
A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2003 Aug 01
Completed
Phase 1
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2009 Jul 13
Completed
Phase 1
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status Start of enrollment: 2009 Mar 01
Completed
Phase 2
Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2010 Jul 01
Completed
Phase 2
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
Completed
Phase 2
Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma Start of enrollment: 2012 Jan 01
Completed
Not Applicable
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) Start of enrollment: 2013 May 06
Completed
Phase 2
A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients Start of enrollment: 2011 Apr 01
Completed
Early Phase 1
Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma Start of enrollment: 2013 Aug 01
Suspended
Phase 1, Phase 2
Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy Start of enrollment: 2014 Jan 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.
Goldlust, S., Duic, P., Benkers, T., Singer, S., Rao, M., Cappello, L., Silberman, S., Farmer, G., Nabors, L., Hsu, S., Mohile, N.> ;Neuro-Oncology Advances. 2024 Jan 18
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
Ye, X., Peerboom, D., Mikkelsen, T., Lesser, G., Fisher, J., Desideri, S., Leopold, L., Fiveash, J., Chowdhary, S., Rosenfeld, M., Grossman, S., Nabors, L.> ;Plos One. 2024 Jan 1
An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.
Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Julius Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Bu...> ;CNS Oncology. 2023 Sep 1
1 citations
Undesired impact of iron supplement on MRI assessment of post-treatment glioblastoma.
Dahye Park, Mina Lobbous, Louis B Nabors, James M Markert, Jinsuh Kim> ;CNS Oncology. 2022 Dec 1
12 citations
The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.
Abhishek Guha, Saboora Waris, Louis B Nabors, Natalia Filippova, Myriam Gorospe, Thaddaeus Kwan, Peter H King> ;Advanced Drug Delivery Reviews. 2022 Feb 1
3 citations
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study.
Lauren R Schaff, Mina Lobbous, Dean Carlow, Ryan Schofield, Igor T Gavrilovic, Alexandra M Miller, Jacqueline B Stone, Anna F Piotrowski, Ugur Sener, Anna Skakodub, Ed...> ;BMC Cancer. 2022 Jan 13
1 citations
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.
Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, Merit E Cudkowicz, Robin A Conwit, Anna L Gudjonsdottir, Dixie J Ecklund, Janel K Fedler, Tina M Neill-Hudson...> ;Neuro-Oncology Advances. 2021 Dec 24
21 citations
A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.
Lawrence S. Lamb, Larisa Pereboeva, Samantha Youngblood, G. Yancey Gillespie, L. Burton Nabors, James M. Markert, Anindya Dasgupta, Catherine P. Langford, H. Trent Spe...> ;Scientific Reports. 2021 Oct 26
1 citations
Mitochondrial DNA sequence variation and risk of meningioma.
Claudine Samanic, Jamie K. Teer, Zachary J. Thompson, Jordan H. Creed, Sepideh Mokhtari, Brooke L. Fridley, L. Burt Nabors, Sion L. Williams, Kathleen M. Egan> ;Journal of Neuro-Oncology. 2021 Oct 20
46 citations
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.
Stephen J Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Louis B. Nabors, Manmeet S Ahluwalia, Roger Stupp, M...> ;Clinical Cancer Research. 2021 Sep 24
2 citations
Data Matching to Support Analysis of Cancer Epidemiology Among Veterans Compared With Non-Veteran Populations-An Exemplar in Brain Tumors.
Christine Woo, Gino Cioffi, Taissa Bej, Brigid Wilson, Janet M Briggs, Sarah C. Markt, Fredrick R. Schumacher, Carol Kruchko, Kristin Waite, L. Burt Nabors, Charles J ...> ;JCO Clinical Cancer Informatics. 2021 Sep 23
9 citations
SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation.
Rajeshwari Chellappan, Abhishek Guha, Ying Si, Thaddaeus Kwan, Louis B. Nabors, Natalia Filippova, Xiuhua Yang, Anish S Myneni, Shriya Meesala, Ashley S. Harms, Peter ...> ;Glia. 2022 Jan 1
5 citations
Multimodal platform for assessing drug distribution and response in clinical trials.
Begoña Gimenez-Cassina Lopez, Ishwar N. Kohale, Ziming Du, Ilya Korsunsky, Walid M. Abdelmoula, Yang Dai, Sylwia A. Stopka, Giorgio Gaglia, Elizabeth C. Randall, Micha...> ;Neuro-Oncology. 2021 Aug 12
16 citations
Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors
Natalia Filippova, Xiuhua Yang, Subramaniam Ananthan, Jennifer A. Calano, Vibha Pathak, Larry Bratton, Rakesh H. Vekariya, Sixue Zhang, Edward Ofori, Emily N. Hayward,...> ;Cancer Research. 2021 Apr 15
15 citations
Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma.
Kory Dees, Hyunmin Koo, J Fraser Humphreys, Joseph A. Hakim, David K. Crossman, Michael R. Crowley, L. Burton Nabors, Etty N. Benveniste, Casey D. Morrow, Braden C. Mc...> ;Neuro-Oncology Advances. 2021 Jan 1
Mapping uncharted territory: a gene expression signature for precision glioblastoma therapeutics.
Kasey R. Skinner, L. Burt Nabors, C. Ryan Miller> ;Neuro-Oncology. 2020 Dec 18
236 citations
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Louis B. Nabors, Jana Portnow, Manmeet Ahluwalia, Joachim Baehring, Henry Brem, Steven Brem, Nicholas Butowski, Jian Campian, Stephen W. Clark, Andrew J. Fabiano, Pete...> ;Journal of the National Comprehensive Cancer Network. 2020 Nov 2
17 citations
ELAVL1 Role in Cell Fusion and Tunneling Membrane Nanotube Formations with Implication to Treat Glioma Heterogeneity
Natalia Filippova, Louis B. Nabors> ;Cancers. 2020 Oct 21
17 citations
Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first worksh...
Stuart A. Grossman, Carlos Romo, Michelle A. Rudek, Jeffrey G. Supko, Joy D. Fisher, L. Burt Nabors, Patrick Y. Wen, David M. Peereboom, Benjamin M. Ellingson, William...> ;Neuro-Oncology. 2020 Oct 1
65 citations
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.
Soniya Bastola, Marat S. Pavlyukov, Daisuke Yamashita, Sadashib Ghosh, Hee Jin Cho, Noritaka Kagaya, Zhuo Zhang, Mutsuko Minata, Yeri Lee, Hirokazu Sadahiro, Shinobu Y...> ;Nature Communications. 2020 Sep 16
6 citations
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
Merit Cudkowicz, Marianne Chase, Christopher S. Coffey, Dixie Ecklund, Brenda Thornell, Codrin Lungu, Katy Mahoney, Laurie Gutmann, Jeremy M. Shefner, Kevin J. Staley,...> ;JAMA Neurology. 2020 Jun 1
26 citations
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
Eudocia Q. Lee, Michael Weller, Joohee Sul, Stephen J Bagley, Solmaz Sahebjam, Martin J. van den Bent, Manmeet Ahluwalia, Jian Campian, Evanthia Galanis, Mark R. Gilbe...> ;Neuro-Oncology. 2020 May 15
2 citations
A troublesome burden, the amplification of EGFR in glioblastoma!
Mina Lobbous, L. Burt Nabors> ;Neuro-Oncology. 2020 May 15
86 citations
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
, , , , , , , , , , , , , , , , , , , , > ;Clinical Cancer Research. 2020 Feb 7
39 citations
An Update on Neurofibromatosis Type 1-Associated Gliomas
Mina Lobbous, Joshua D. Bernstock, Elizabeth Coffee, Gregory K. Friedman, Laura K. Metrock, Gustavo Chagoya, Galal A. Elsayed, Ichiro Nakano, James R. Hackney, Bruce R...> ;Cancers. 2020 Jan 1
Join now to see all

Journal Articles

Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma
Louis B Nabors, April Eichler, Clinical Cancer Research

Hospital Affiliations

UAB HighlandsBirmingham, Alabama
University of Alabama HospitalBirmingham, Alabama
USA Health University HospitalMobile, Alabama
DCH Regional Medical CenterTuscaloosa, Alabama
DCH Regional Medical CenterTuscaloosa, Alabama
DCH Regional Medical CenterTuscaloosa, Alabama
DCH Regional Medical CenterTuscaloosa, Alabama
DCH Regional Medical CenterTuscaloosa, Alabama
DCH Regional Medical CenterTuscaloosa, Alabama